Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers

NCT02279589 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL: Pneumo 23® 0,5
BIOLOGICAL: Pneumo 23® 0,1
BIOLOGICAL: Prevenar13® 0,5

Sponsor

Assistance Publique - Hôpitaux de Paris